2019
DOI: 10.21608/mjvh.2019.55731
|View full text |Cite
|
Sign up to set email alerts
|

The role of interleukin-2 and interleukin-4 in disease progression in patients with schistosomiasis combined with chronic viral hepatitis C and chronic viral hepatitis B

Abstract: Human schistosomiasis is one of the most harmful parasitic diseases. It is reported to be endemic in 77 countries in tropical and subtropical regions, leading to infection of about 250 million individuals universal 1 . Schistos-omiasis is a disease caused predominantly by the host's immune response to schistosoma ova and the granulomatous reaction they induce 1-6 . The granulomas destroy the eggs and sequester or neutralize otherwise pathogenic egg antigens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 17 publications
(19 reference statements)
0
1
0
Order By: Relevance
“…Schistosomal infection encourages immune suppression by up-regulation of type 2 responses (Th-2) while downregulating Th-1 responses, leading to persistence of concomitant viral infections. Co-infection with schistosomiasis and HCV was found to have more severe effects on liver pathology and progression into worsening complications than HCV infection alone [37][38][39] .…”
Section: Discussionmentioning
confidence: 99%
“…Schistosomal infection encourages immune suppression by up-regulation of type 2 responses (Th-2) while downregulating Th-1 responses, leading to persistence of concomitant viral infections. Co-infection with schistosomiasis and HCV was found to have more severe effects on liver pathology and progression into worsening complications than HCV infection alone [37][38][39] .…”
Section: Discussionmentioning
confidence: 99%